InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (10 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
10
T+90 hit rate
20%
T+90 mean return
-23.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Labrucherie Gil M, Chief Financial Officer. Director active across 5 companies, notably NEKTAR THERAPEUTICS. Aggregated, 23 reports have been logged. Split: 4 buys · 10 sells. Total volume traded: €1.5m. History available since 17 May 2021. The latest transaction was filed on 25 February 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations23 total
6,282 shares@ US$5.5937.8% of flowCommon StockSEC:0000950170-25-029330:0
Ideal exit: 22 Nov 2025 (T+270)
10,500 shares@ US$5.50662.2% of flowCommon StockSEC:0000950170-25-025039:0
Ideal exit: 16 Nov 2025 (T+270)
25,500 shares0Common SharesSEC:0000912282-25-000184:0
40,763 shares0Common StockSEC:0001962918-23-000034:0
28,750 shares0Common StockSEC:0001209191-22-029899:0
52,631 shares@ US$3.800.049% mcap50.0% of flowCommon StockSEC:0001567619-22-009789:0
Ideal exit: 29 Jan 2023 (T+270)
52,631 shares@ US$3.800.049% mcap50.0% of flowCommon StockSEC:0001567619-22-009699:0
Ideal exit: 29 Jan 2023 (T+270)
7,579 shares@ US$10.950.0031% mcap6.9% of flowCommon StockSEC:0001209191-22-011436:0
7,579 shares@ US$10.950.0031% mcap13.8% of flowCommon StockSEC:0001209191-22-011436
52,950 shares0Common StockSEC:0001209191-21-070690
52,950 shares0Common StockSEC:0001209191-21-070690:0
21,149 shares@ US$13.1623.1% of flowCommon StockSEC:0001209191-21-065592
21,149 shares@ US$13.160.010% mcap23.1% of flowCommon StockSEC:0001209191-21-065592:0
40,150 shares0Common StockSEC:0001209191-21-065220:0
40,150 shares0Common StockSEC:0001209191-21-065220
7,867 shares@ US$13.830.0039% mcap8.7% of flowCommon StockSEC:0001209191-21-052384:0
7,867 shares@ US$13.838.7% of flowCommon StockSEC:0001209191-21-052384
7,898 shares@ US$18.3011.2% of flowCommon StockSEC:0001209191-21-034184
7,898 shares@ US$18.300.0050% mcap11.2% of flowCommon StockSEC:0001209191-21-034184:0
11,666 sharesCommon StockSEC:0001209191-16-098173:0
11,666 sharesCommon StockSEC:0001209191-16-098173:1
11,667 sharesCommon StockSEC:0001209191-16-092942:0
11,667 sharesCommon StockSEC:0001209191-16-092942:1
23 of 23 declarations
About Labrucherie Gil M
Gil M Labrucherie is an executive at NEKTAR THERAPEUTICS.
